-
Head of Clinical Development Platform, Translational Research Specialist ,
Berlin-Brandenburger Centre for Regenerative Therapies (BCRT); Charité Universitätsmedizin Berlin
-
Head of Cell Therapy Development ,
Lonza
-
Director of Business Development ,
MolMed
-
Project Leader, ATMP's ,
Chiesi Farmaceutici SpA
-
Industrialization Manager ,
Celyad
-
Manager ,
GlaxoSmithKline
-
Chief Financial Officer ,
Celixir
-
CEO ,
Boyds
-
Director ,
Advanced Biologicals Ltd
-
Head, Cellular Therapy Immuno-Oncology ,
GlaxoSmithKline
-
Chief Scientific Officer ,
Cellex Patient Treatment GmbH
-
Chief Technology and Manufacturing Officer ,
Bone Therapeutics
-
Programme Director, Scientific Affairs, Centre for Health Technology Evaluation ,
National Institute for Health & Care Excellence
-
Senior Vice President, Global Clinical Oncology Development ,
Merck Sharpe & Dohme
-
President ,
Dark Horse Consulting
-
CEO ,
Gadeta
-
Vice President, Manufacturing and Research & Development ,
Rexgenero
-
CTO ,
BlueRock Therapeutics
-
Principal & Senior Consultant ,
Dark Horse Consulting, Inc
-
Vice President of Operations ,
OncoSec
-
Chief Scientific Officer & General Manager ,
Lentigen Technology, Inc A Miltenyi Company
-
Chief Business Officer ,
Cell and Gene Therapy Catapult
-
Chief Executive Officer ,
Tactiva Therapeutics, Inc
-
Vice President, Regulatory Science ,
blubird bio
-
President and Chief Executive Officer ,
MedCision
-
Senior Manager, Advanced Therapies ,
Fisher BioServices
-
Director, Regulatory Affairs, Cell & Gene Therapies ,
ERA Consulting
-
Senior Vice President & Head of Manufacturing ,
Autolus Ltd
-
Chief Scientific Officer & Managing Director ,
CEVEC Pharmaceuticals
-
Senior Pharmaceutical Analyst and European Head ,
Bloomberg Intelligence
-
CEO / Managing Director; Chief Commercialisation Officer and Chair of Commercialisation Committee ,
Zelluna Immunotherapy / ISCT
-
Vice President, Cell Therapy Operations ,
Orchard Therapeutics
-
Field Marketing Manager EU, Regenerative Medicine ,
Sartorious Stedim Biotech GmbH
-
Chief Clinical and Regulatory Officer ,
OnoSec Medical Incorporated
-
Vice President R&D ,
Celyad
-
Vice President, Global Medical Affairs, Immunotherapy ,
Celgene
-
CEO & Medical Director ,
apceth Biopharma GmbH
-
Chief Medical Officer ,
Oncolytics Biotech Inc
-
Senior Vice President, Head of External Innovation and Head of TIP Immuno-Oncology Global Research & Development Biopharma ,
Merck KGaA
-
Vice President Marketing & Sales ,
CellGenix
-
PharmD, VP Process Development ,
TxCell
-
Senior Scientist ,
B-MoGen Biotechnologies
-
Head, Process Research, Cell & Gene Therapy Platform CMC ,
GlaxoSmithKline
-
Global CMC Head & Director, Cell & Gene Therapy Unit ,
Novartis Pharma AG
-
CMO, Head of R&D ,
Targovax
-
Chief Executive Officer ,
VEL Biosciences
-
CFO ,
Celyad
-
QM/Head of Quality Control, GMP Facility ,
Charité University Hospital, Berlin
-
Vice President & Head of Cell & Gene Therapy Development, Rare Disease Unit ,
GlaxoSmithKline
-
Research Director ,
ToolGen
-
Managing Director ,
EUFETS GmbH
-
Managing Partner ,
4BIO Capital
-
Vice President, Scientific Affairs ,
TrakCel
-
Managing Partner ,
Kurma Partners
-
Vice President Development & Production ,
CellGenix
-
Chief Executive Officer ,
Merus
-
Director of Cellular Therapeutics; Professor of Cell & Tissue Therapy ,
Royal Free Hospital; University College London
-
Vice President, Manufacturing and Supply Chain ,
Adaptimmune
-
Clinical & Regulatory Expert; EMACAT & CHMP Member ,
Lithuanian State Medicines Control Agency
-
Director of Operations ,
Synpromics
-
Device Manager - Device Technology, Biologics Technical Development and Manufacturing (BTDM) ,
Novartis Pharma AG
-
Principal ,
Medicxi
-
BioProcess Applications Engineer ,
PendoTECH
-
Lead Technical Scientist ,
Cell & Gene Therapy Catapult
-
Process Science Manager ,
CMC, ReNeuron
-
Member of the Committee for Advanced Therapies and of the Biologics Working Party ,
European Medicines Agency (EMA)
-
CEO ,
TCR2 Therapeutics Inc
-
COO ,
Arthrogen
-
Head Innovative Pricing, Global Pricing and Market Access ,
F-Hoffman - La Roche
-
Head of Unit, Safety of Gene Therapy & Insertional Mutagenesis Research Unit ,
San Raffaele Telethon Institute for Gene Therapy (SR-TIGET)
-
Vice-President, Disruptive Biologics ,
Voisin Consulting Life Sciences
-
CAT Member; Senior Quality Assessor ,
UK Medicines and Healthcare Products Regulatory Agency (MHRA)
-
Vice President, Program Management ,
Biogen
-
Head of Department, Care Management Development ,
DAK-Gesundheit - Germany
-
Chief Technology Officer ,
Oxford Genetics
-
Chief Scientific Officer, Executive Vice President, Cellular Therapies ,
MaxCyte
-
Vice President, ImmunoOncology Clinical Strategy ,
Bavarian Nordic
-
Senior Vice President, Medical Affairs & Chief Medical Officer ,
Medigene AG
-
CSO ,
iTeos Therapeutics
-
Senior Director of AAV Capsid Development ,
Pfizer
-
Vice President & Global Head of Oncology BD&L ,
Novartis
-
Senior Director, Technical Operations ,
TiGenix
-
President; Chief Executive Officer ,
YposKesi; Genethon
-
Chief Regulatory and Compliance Officer ,
Cellectis
-
Policy Officer, DG Health ,
European Commission
-
Chief Operating Officer ,
Inovio Pharmaceuticals
-
Chief Scientific Officer ,
Erytech
-
CEO ,
Provecs Medical
-
CEO ,
CELLMED
-
Department of Transplantology and Central Tissue Bank, Member, Committee for Advanced Therapies (CAT) ,
Medical University of Warsaw, European Medicines Agency (EMA)
-
Head of Business Development ,
Oxford Biomedica
-
Vice President of Corporate Development & Strategy ,
BlueRock Therapeutics
-
PhD, Chief Scientific Officer ,
Glycostem
-
Business Development Consultant ,
PendoTECH
-
Chief Medical Officer & Head of R&D ,
Orchard Therapeutics
-
Senior Manager, Business Development ,
PCT, a Caladrius Company
-
Chief Business Officer ,
Adaptimmune
-
Chief Development Officer ,
Freeline Therapeutics
-
Head of Commercial Strategy ,
Immunocore
-
Director ,
Simon-Kucher & Partners